Chile ISP Technical Guidance: The 12-Month Window and Voluntary Verification

1. Key takeaways

Exempt Decree No. 25/2026 provides a clear early-mover entry point: the ISP must publish its technical guidance within 12 months of publication, and once the guidance is issued, manufacturers and importers may voluntarily apply for conformity verification without waiting for the mandatory deadline. Counting from the publication date of 19 March 2026, the guidance is expected around March 2027.

GRZAN’s recommendation comes down to three actions: complete roughly 80% of the documentation engineering before the guidance is published, submit immediately after publication, and use the voluntary status to secure a place in the first wave of reviews. This is not speculation. It is converting a choice explicitly offered by the regulation into a measurable time advantage, because review capacity at the ISP is finite and the queue will lengthen rapidly once the guidance opens the gate for everyone. The companies that treat the 12-month guidance window as their own preparation window will enter the procedure with finished files; the companies that treat it as waiting time will enter it with drafts, and the difference in effective review time can be measured in quarters, not weeks.

2. Legal basis

• Bringing the listed devices under the sanitary control regime of Article 111 | Decreto Exento N° 25, de 2026 | 19 March 2026 | Transitional provisions: the Public Health Institute must publish technical guidance within 12 months of publication, defining the procedure and documentation requirements for conformity verification; before that, manufacturers and importers may voluntarily initiate conformity verification procedures.
• Same instrument | Transition period provisions: implantable and higher-risk devices, 24 months; all other devices, 36 months.
• Sanitary Code | DFL N° 725, de 1967 | Article 111, subparagraphs a) and b) | verification and certification are carried out by ISP-authorized bodies; where none exist, the ISP implements them itself.
• Regulation on the control of medical products and devices | Decreto Supremo N° 825, de 1998 | 21 August 1999 | Article 21: documentation requirements by class.

3. Expert insights

Insight 1: voluntary application is a transitional provision, not an exceptional permit.

The provision places voluntary application inside the transitional provisions (disposición transitoria) of the decree. That placement means it is a routine channel designed by the legislator to smooth the transition, not an individual approval that requires special justification. A company does not need to demonstrate why it wants to move early; it only needs to satisfy the documentation requirements. This distinction matters in internal decision-making: teams that misread the voluntary route as an exception tend to over-prepare arguments and under-prepare documents, which is exactly the wrong allocation of effort. Reading the provision as written keeps the project focused where the reviewer will actually look.

Insight 2: the entry point opens after the guidance is published, but the preparation can be finished before publication.

The sequence written into the provision is: publication, then guidance within 12 months, then voluntary applications. GRZAN splits this into two parallel tracks. Guidance-dependent items — product-specific checklists and procedural details — must wait for publication. Guidance-independent items — the ISO 13485 certificate, risk management documentation, Spanish labels and instructions for use, and the CFS with its apostille chain — can be produced now. In practice, the guidance-independent portion accounts for the majority of the documentation workload, so most of the project can run without waiting for the ISP.

Insight 3: the benefit of moving early is not an earlier certificate — it is avoiding the queue.

The ISP must carry out verification for the newly listed categories itself, and its review resources are limited. The mandatory deadlines of the 24-month and 36-month tracks differ, but the submission surge is the same: large numbers of companies will file in a concentrated window across 2027 and 2028. The practical benefit of moving early is therefore not calendar acceleration of the procedure itself; it is putting your dossier at the front of that single queue, before the surge raises effective waiting times for everyone who arrives later. For portfolio decisions, that means the value of early submission grows with the number of SKUs you intend to place on the Chilean market, because a front-of-queue position protects the whole launch sequence, not just the first product.

Insight 4: moving early also carries a cost, and the risk of rework after guidance changes must be assessed.

The first submissions after publication may meet subsequent adjustments to procedural details. GRZAN’s approach is to organize documentation in a modular structure: generic modules are built once and finalized, while product-specific modules are built with interfaces so that a minor change in the guidance only requires replacing the affected module, not reworking the entire package. This structure turns the uncertainty of an early submission from a portfolio-wide risk into a contained, module-level one. It also shortens internal review cycles, because changes are evaluated at the module boundary where the guidance actually touched, and the rest of the file carries an unchanged audit trail.

4. Practical recommendations

1. Build a two-column documentation list, guidance-independent versus guidance-dependent: start the former immediately and hold the latter until publication.
2. Finalize the generic base in one pass: ISO 13485 certificate, risk management plan and report, Spanish labels and instructions for use, and the CFS with its apostille document chain.
3. Organize the technical file in modules so that minor guidance adjustments only require replacing product-specific modules instead of reworking the whole package.
4. Synchronize scheduling with the Chilean registration holder: entity incorporation, warehouse authorization and GICONA user registration can all run in parallel with documentation engineering.
5. Set up a guidance monitoring mechanism: complete a gap comparison within 48 hours of ISP publication and update the documentation list accordingly.

5. Verification checklist

• □ The 12-month statutory period for the guidance and the expected milestone (March 2027) have been recorded
• □ A two-column documentation list, guidance-independent versus guidance-dependent, has been produced
• □ Generic base documentation (ISO 13485, risk management, Spanish labels and instructions for use, CFS, apostille) has been started
• □ The technical file has been organized in a modular structure
• □ A 48-hour gap comparison mechanism for guidance publication has been established

Regulatory information verified as of 29 October 2026.

GRZAN supports manufacturers entering the Chilean market with ISP registration pathways and classification strategy, including voluntary verification timing, modular dossier design and guidance monitoring. For a feasibility assessment of your specific product, contact the GRZAN regulatory team at info@grzanglobal.com.